Evaluation of the effects of intravascular MR contrast media (gadolinium dendrimer) on 3D time of flight magnetic resonance angiography of the body

The aims of this preliminary study were to establish the efficacy and minimum effective dose of TG5(FdDO3A)52 gadolinium dendrimer for contrast‐enhanced, three‐dimensional (3D) time of flight (TOF) magnetic resonance angiography (MRA) of the body. In a dose ranging study in eight rabbits (Group A), each of two animals received 0.03; 0.02; 0.01; or 0.005 mmol/kg of the agent for 3D‐TOF MRA of the pelvic circulation in the axial and coronal planes. An additional nine animals (Group B) received a dose of 0.02 mmol/kg for 3D‐TOF MRA of the mediastinum, abdomen or of the lower limbs. Quantitative and qualitative analyses of the images from Group A demonstrated a dose‐related reduction in saturation effects and improved visualization of vascular structures, with maximal augmentation of the contrast‐to‐noise ratio (CNR) at 0.03 mmol/kg. The dose of 0.02 mmol/kg was found to be the minimal effective dose at the three vascular regions.

[1]  H. Rennke,et al.  Glomerular permeability of macromolecules. Effect of molecular configuration on the fractional clearance of uncharged dextran and neutral horseradish peroxidase in the rat. , 1979, The Journal of clinical investigation.

[2]  H Bosmans,et al.  Experimental Gd-DTPA polylysine enhanced MR angiography: sequence optimization. , 1991, Journal of computer assisted tomography.

[3]  M. Prince.  Gadolinium-enhanced MR aortography. , 1990, Radiology.

[4]  M. Moseley,et al.  Evaluation of Gd-DTPA-labeled dextran as an intravascular MR contrast agent: imaging characteristics in normal rat tissues. , 1990, Radiology.

[5]  D Saloner,et al.  Assessment of carotid artery stenosis by MR angiography: comparison with x-ray angiography and color-coded Doppler ultrasound. , 1992, AJNR. American journal of neuroradiology.

[6]  M. Moseley,et al.  Albumin labeled with Gd-DTPA. An intravascular contrast-enhancing agent for magnetic resonance blood pool and perfusion imaging. , 1990, Acta radiologica. Supplementum.

[7]  V M Runge,et al.  Contrast‐enhanced MR angiography , 1993, Journal of magnetic resonance imaging : JMRI.

[8]  J. Michiels,et al.  Contrast-enhanced MRA of the brain. , 1992, Journal of computer assisted tomography.

[9]  R A Robb,et al.  A software system for interactive and quantitative visualization of multidimensional biomedical images. , 1991, Australasian physical & engineering sciences in medicine.

[10]  S. Weisbroth,et al.  The Biology of the Laboratory Rabbit , 1974 .

[11]  R. Weissleder,et al.  Enhancement of MR angiography with iron oxide: preliminary studies in whole-blood phantom and in animals. , 1994, AJR. American journal of roentgenology.

[12]  H. Bosmans,et al.  MR angiography with gadopentetate dimeglumine-polylysine: evaluation in rabbits. , 1990, AJR. American journal of roentgenology.

[13]  R. Patt,et al.  Gadolinium-enhanced magnitude contrast MR angiography of popliteal and tibial arteries. , 1992, Radiology.

[14]  R. Edelman.  MR angiography: present and future. , 1993, AJR. American journal of roentgenology.

[15]  J. Lewin,et al.  Intracranial MR angiography: a direct comparison of three time-of-flight techniques. , 1991, AJNR. American journal of neuroradiology.

[16]  P C Lauterbur,et al.  Dendrimer‐based metal chelates: A new class of magnetic resonance imaging contrast agents , 1994, Magnetic resonance in medicine.

[17]  James R. Dewald,et al.  A New Class of Polymers: Starburst-Dendritic Macromolecules , 1985 .